Journal
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
Volume 26, Issue 6, Pages 344-354Publisher
ESMON PUBLICIDAD S A, DEPT ALLERGY
DOI: 10.18176/jiaci.0122
Keywords
Thermotolerant fungi; Allergic fungal airway disease (AFAD); ABPA; SAFS; Asthma; Allergic fungal rhinosinusitis (AFRS); Immune responses; Diagnosis; Treatment
Categories
Funding
- National Institute for Health Research (NIHR) Leicester Respiratory Biomedical Research Unit
- National Institute for Health Research (NIHR)
- Asthma UK
- Midlands Asthma and Allergy Research Association (MAARA)
- Asthma UK [AUK-PHD-2013-250] Funding Source: researchfish
Ask authors/readers for more resources
Fungi are ubiquitous and form their own kingdom. Up to 80 genera of fungi have been linked to type I allergic disease, and yet, commercial reagents to test for sensitization are available for relatively few species. In terms of asthma, it is important to distinguish between species unable to grow at body temperature and those that can (thermotolerant) and thereby have the potential to colonize the respiratory tract. The former, which include the commonly studied Alternaria and Cladosporium genera, can act as aeroallergens whose clinical effects are predictably related to exposure levels. In contrast, thermotolerant species, which include fungi from the Candida,Aspergillus, and Penicillium genera, can cause a persistent allergenic stimulus independent of their airborne concentrations. Moreover, their ability to germinate in the airways provides a more diverse allergenic stimulus, and may result in noninvasive infection, which enhances inflammation. The close association between IgE sensitization to thermotolerant filamentous fungi and fixed airflow obstruction, bronchiectasis, and lung fibrosis suggests a much more tissue-damaging process than that seen with aeroallergens. This review provides an overview of fungal allergens and the patterns of clinical disease associated with exposure. It clarifies the various terminologies associated with fungal allergy in asthma and makes the case for a new term (allergic fungal airway disease) to include all people with asthma at risk of developing lung damage as a result of their fungal allergy. Lastly, it discusses the management of fungi related asthma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available